Vaccine equity remains a global issue after nearly two years since COVID-19 struck, as only two percent of over 5.5 billion doses administered globally had gone to recipients in low-income nations.
In the long run, there is a need for global accountability in pandemic preparedness, but in the immediate term there must be greater global solidarity to ultimately end the COVID-19 pandemic.
Malaysia recognises the importance of and will pursue global public health equity, which includes working towards establishing deeper medical and pharmaceutical cooperation both at home and abroad to ensure that we, as well as our partners, are better prepared to face the current and future health crises.